We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.36B
AUM Growth
+$242M
Cap. Flow
+$106M
Cap. Flow %
4.48%
Top 10 Hldgs %
34.74%
Holding
3,215
New
294
Increased
1,348
Reduced
581
Closed
158

Sector Composition

Rank Sector Weight
1 Technology 15.92%
2 Financials 7.56%
3 Healthcare 5.92%
4 Communication Services 5.21%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRC icon
2676
Ameresco
AMRC
$1.36B
$1K ﹤0.01%
8
ANAB icon
2677
AnaptysBio
ANAB
$1.68B
$1K ﹤0.01%
42
ARCT icon
2678
Arcturus Therapeutics
ARCT
$211M
$1K ﹤0.01%
20
ARTNA icon
2679
Artesian Resources
ARTNA
$358M
$1K ﹤0.01%
28
ARVN icon
2680
Arvinas
ARVN
$572M
$1K ﹤0.01%
17
ASIX icon
2681
AdvanSix
ASIX
$444M
$1K ﹤0.01%
23
+8
+53% +$240
ASTS icon
2682
AST SpaceMobile
ASTS
$21.5B
$1K ﹤0.01%
+54
New +$486
ATEC icon
2683
Alphatec Holdings
ATEC
$1.44B
$1K ﹤0.01%
+61
New +$941
ATKR icon
2684
Atkore
ATKR
$3.16B
$1K ﹤0.01%
14
ATNI icon
2685
ATN International
ATNI
$492M
$1K ﹤0.01%
11
ATOM icon
2686
Atomera
ATOM
$214M
$1K ﹤0.01%
35
AUTL
2687
Autolus Therapeutics
AUTL
$562M
$1K ﹤0.01%
+180
New +$1.12K
AVDL
2688
DELISTED
Avadel Pharmaceuticals
AVDL
$1K ﹤0.01%
+128
New +$1.02K
AVIR icon
2689
Atea Pharmaceuticals
AVIR
$420M
$1K ﹤0.01%
+43
New +$1.29K
DCH
2690
Dauch Corp
DCH
$1.51B
$1K ﹤0.01%
+115
New +$1.21K
AXSM icon
2691
Axsome Therapeutics
AXSM
$10.9B
$1K ﹤0.01%
17
AZEK
2692
DELISTED
The AZEK Co
AZEK
$1K ﹤0.01%
31
-419
-93% -$18.8K
BAB icon
2693
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
$1K ﹤0.01%
15
-1
-6% -$33
BAR icon
2694
GraniteShares Gold Shares
BAR
$1.46B
$1K ﹤0.01%
+37
New +$667
BEAM icon
2695
Beam Therapeutics
BEAM
$2.84B
$1K ﹤0.01%
10
BGC icon
2696
BGC Group
BGC
$4.89B
$1K ﹤0.01%
151
BHR
2697
Braemar Hotels & Resorts
BHR
$142M
$1K ﹤0.01%
+225
New +$1.39K
BOLT icon
2698
Bolt Biotherapeutics
BOLT
$7.78M
$1K ﹤0.01%
+3
New +$1.22K
CAC icon
2699
Camden National
CAC
$976M
$1K ﹤0.01%
20
CALX icon
2700
Calix
CALX
$2.39B
$1K ﹤0.01%
13

Similar funds

Parallel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Parallel Advisors held 3,215 positions worth $2.36B, up 11% from $2.12B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $106M of net new capital in Q2 2021, opening 294 new positions and adding to 1,348 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 118,367 shares worth $3.19M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Treasury Bond ETF, an estimated $8.53M trimmed.

  • Parallel Advisors's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 118,367 shares worth $3.19M.
  • Parallel Advisors added most to State Street Energy Select Sector SPDR ETF in Q2 2021, an estimated $14.3M increase.
  • Parallel Advisors's biggest Q2 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $8.53M.
  • Parallel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $365K.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.36B portfolio in Q2 2021.
  • Parallel Advisors opened 294 new positions and closed 158 in Q2 2021.
  • Parallel Advisors's portfolio value rose 11% quarter-over-quarter to $2.36B.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.